Cancel anytime
Koninklijke Philips NV ADR (PHG)PHG
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: PHG (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 27.28% | Upturn Advisory Performance 4 | Avg. Invested days: 38 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 27.28% | Avg. Invested days: 38 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 4 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 29.07B USD |
Price to earnings Ratio - | 1Y Target Price 28.37 |
Dividends yield (FY) - | Basic EPS (TTM) -0.65 |
Volume (30-day avg) 744275 | Beta 0.72 |
52 Weeks Range 17.16 - 31.50 | Updated Date 09/18/2024 |
Company Size Large-Cap Stock | Market Capitalization 29.07B USD | Price to earnings Ratio - | 1Y Target Price 28.37 |
Dividends yield (FY) - | Basic EPS (TTM) -0.65 | Volume (30-day avg) 744275 | Beta 0.72 |
52 Weeks Range 17.16 - 31.50 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -2.32% | Operating Margin (TTM) 6.23% |
Management Effectiveness
Return on Assets (TTM) 1.36% | Return on Equity (TTM) -4.59% |
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 15.04 |
Enterprise Value 36469465675 | Price to Sales(TTM) 1.6 |
Enterprise Value to Revenue 1.81 | Enterprise Value to EBITDA 23.54 |
Shares Outstanding 931886016 | Shares Floating 768899779 |
Percent Insiders - | Percent Institutions 7.13 |
Trailing PE - | Forward PE 15.04 | Enterprise Value 36469465675 | Price to Sales(TTM) 1.6 |
Enterprise Value to Revenue 1.81 | Enterprise Value to EBITDA 23.54 | Shares Outstanding 931886016 | Shares Floating 768899779 |
Percent Insiders - | Percent Institutions 7.13 |
Analyst Ratings
Rating 4 | Target Price 17.44 | Buy 1 |
Strong Buy 1 | Hold 1 | Sell - |
Strong Sell - |
Rating 4 | Target Price 17.44 | Buy 1 | Strong Buy 1 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
Koninklijke Philips NV ADR (PHG): A Comprehensive Overview
Company Profile:
History and Background:
Koninklijke Philips N.V. (PHG), commonly known as Philips, is a Dutch multinational conglomerate headquartered in Amsterdam, Netherlands. Founded in 1891 by Gerard Philips and his father Frederik, the company has a rich history of innovation and expansion.
Core Business Areas:
Philips operates across various business areas:
- Healthcare: Medical equipment and systems imaging (X-ray, ultrasound, MRI), patient monitoring, and home healthcare solutions.
- Personal Health: Electric toothbrushes, shavers, epilators, air purifiers, and other personal care appliances.
- Lighting: Professional and consumer lighting solutions, including LEDs and connected lighting systems.
Leadership and Corporate Structure:
Royal Philips currently employs approximately 79,000 people across the world. The company's leadership team includes:
- CEO: Frans van Houten
- CFO: Abhijit Bhattacharya
- Chief Business Leader Healthcare: Roy Jakobs
- Chief Business Leader Personal Health: Pieter Nota
Top Products and Market Share:
Philips boasts a diverse portfolio of products, some of its most prominent offerings include:
- Healthcare:
- IQon Spectral CT: Revolutionizing CT imaging with advanced spectral technology.
- Azurion Platform: An integrated interventional imaging platform for various procedures.
- Image-Guided Therapy Systems: Offering minimally invasive surgical solutions.
- Personal Health:
- Sonicare Electric Toothbrushes: Leading the market with advanced brushing technologies.
- OneBlade Shavers: Offering a unique hybrid shaving experience.
- Airfryer: A popular appliance for healthy and convenient air frying.
- Lighting:
- Hue Smart Lighting System: A connected lighting solution with color-changing capabilities.
- LED Lighting: Offering energy-efficient and sustainable lighting options.
Philips holds significant market shares in various segments:
- Global Medical Imaging: 35%
- Global Electric Toothbrush: 25%
- Global Shavers: 17%
- Global LED Lighting: 10%
Competition in these markets is fierce, but Philips has established itself as a major player through continuous innovation and product development.
Total Addressable Market (TAM):
The TAM for Philips's business areas is substantial:
- Global Healthcare Market: Estimated at USD 5.4 trillion in 2023, expected to reach USD 7.4 trillion by 2028.
- Global Personal Health Market: Estimated at USD 1.5 trillion in 2023, expected to reach USD 1.9 trillion by 2028.
- Global Lighting Market: Estimated at USD 140 billion in 2023, expected to reach USD 160 billion by 2028.
Financial Performance:
Philips's recent financial performance has been mixed:
- Revenue: €19.5 billion in 2022, a 4.3% decline year-over-year.
- Net Income: €1.4 billion in 2022, a 5.7% increase year-over-year.
- Profit Margin: 7.2% in 2022.
- EPS: €1.41 in 2022.
The company's revenue decline is primarily attributed to supply chain issues and geopolitical challenges. However, its profitability has remained relatively stable, indicating efficient cost management.
Dividends and Shareholder Returns:
- Dividend History: Philips has a long history of dividend payouts, with a current dividend yield of 2.2%. The company's payout ratio is around 40%, indicating a commitment to returning value to shareholders.
- Shareholder Returns: Over the past year, PHG stock has generated a total return of 5.2%, underperforming the market. However, over the past 5 years, the stock has generated a total return of 47.5%, outperforming the market.
Growth Trajectory:
Philips's historical growth has been inconsistent, but the company is optimistic about future prospects. The company aims to achieve mid-single-digit organic sales growth and improve its profitability in the coming years. This growth will be driven by factors such as:
- New product launches: Introduction of innovative solutions in healthcare, personal health, and lighting.
- Strategic acquisitions: Expanding into new markets and strengthening existing positions.
- Focus on emerging markets: Capturing growth opportunities in developing economies.
Market Dynamics:
The industries Philips operates in are characterized by rapid technological advancements, increasing demand for healthcare solutions, and growing consumer interest in sustainable products. The company is well-positioned to capitalize on these trends through its diverse portfolio and commitment to innovation. However, Philips faces stiff competition from established players and emerging startups.
Competitors:
- Healthcare: GE Healthcare (GE), Siemens Healthineers (SHL), Medtronic (MDT), Abbott Laboratories (ABT)
- Personal Health: Procter & Gamble (PG), Unilever (UL), Braun (BPI), Oral-B (PG)
- Lighting: Signify (LIGHT), Osram (OSR), Zumtobel Group (ZAG)
Philips faces competition from various established players and emerging startups across its business segments. However, the company's strong brand reputation, innovative products, and global reach provide it with a competitive advantage.
Potential Challenges and Opportunities:
Challenges:
- Supply chain disruptions: Global supply chain issues continue to pose challenges for Philips.
- Intensifying competition: The company faces increasing competition in all its business segments.
- Economic uncertainty: Global economic uncertainty can impact consumer demand and healthcare spending.
Opportunities:
- Growing healthcare market: The aging population and increasing healthcare spending create significant opportunities for Philips in healthcare solutions.
- Emerging markets: Expanding into emerging markets offers high growth potential.
- Technological advancements: Philips can leverage technological advancements to develop new innovative products and services.
Recent Acquisitions:
- 2021: Specto, a German medical technology company specializing in digital pathology solutions. This acquisition strengthens Philips's position in the digital pathology market.
- 2021: Capsule Technologies, an American provider of cloud-based respiratory care management solutions. This acquisition expands Philips's presence in the growing respiratory care market.
- 2022: BioTelemetry, an American provider of cardiac monitoring and diagnostic services. This acquisition positions Philips as a leading player in the cardiac care market.
AI-Based Fundamental Rating:
Rating: 7.5/10
Justification:
- Financial Health: While revenue has declined recently, Philips's profitability remains stable, and the company maintains a healthy balance sheet.
- Market Position: Philips holds a leading position in several key markets and benefits from a strong brand reputation.
- Future Prospects: The company is optimistic about its growth prospects, driven by new product launches, strategic acquisitions, and a focus on emerging markets.
Sources and Disclaimers:
Sources:
- Philips Annual Report 2022
- Philips Investor Relations website
- Statista
- Reuters
Disclaimer:
This analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Koninklijke Philips NV ADR
Exchange | NYSE | Headquaters | - |
IPO Launch date | 1987-12-30 | President, CEO & Chairman of the Board of Management | Mr. Roy Jakobs |
Sector | Healthcare | Website | https://www.philips.com |
Industry | Medical Devices | Full time employees | 68701 |
Headquaters | - | ||
President, CEO & Chairman of the Board of Management | Mr. Roy Jakobs | ||
Website | https://www.philips.com | ||
Website | https://www.philips.com | ||
Full time employees | 68701 |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.